CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


<
Celgene Corp  (CELG)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 


 

Celgene Corp

CELG's Financial Statements and Analysis






Celgene Corp reported in II. Quarter net earnings per share of $1.43 an increase by 9.16 % year on year from $1.31 and an improvement of 30 % from $1.10 realized in I. Quarter (Mar 31 2018).

Celgene's Revenue rose by % in II. Quarter (Jun 30 2018) year on year, to $3,814 million and advanced by 7.8 % sequentially.


Celgene is Expected to report next financial results on October 23, 2018.
More on CELG's Income Statement

II. Quarter
Earnings Per Share Revenues
$ 1.43 $  3,814 Mill
$+0.12     +9.16 % $+546M     +16.71 %
You need to upgrade your Flash Player


       
  • REVLIMID 11.81% Y/Y,
• ABRAXANE 8.34% Y/Y,
• Other 350% Y/Y,
• Total product sales 18.18% Y/Y,
• ISTODAX 10.19% Y/Y,
• POMALYST, IMNOVID 41.63% Y/Y,
• azacitidine injection 7.04% Y/Y
   
     
       
  • THALOMID -13.1% Y/Y,
• VIDAZA -6.46% Y/Y
   
     


CELG's Segments

CELG's NET INCOME

Celgene's net income of $1,045 million in II. Quarter decreased by -1.51 % from net earnings of $1,061 million achieved in II. Quarter a year ago.

Sequentially net earnings grew by 23.52 % from net income of $846.00 million realized in previous quarter.

More on CELG's Growth

Inventories Inventories grew by 4.13 % to $555 million from II. Quarter a year ago, sequentially inventories rose by 3.54 %. In II. Quarter company's net cash and cash equivalents decreased by $-1,316 million, capital expenditures fell by 14.29%, to $-80 millions compare to same quarter a year ago and rose by -9.09% from I. Quarter (Mar 31 2018).

More on CELG's Cash flow Statement



Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 5.02 cash per share, on a free-cash flow basis 138.04 % of net earning per share.

Book value fell by -30.45 % sequentially to $4.68 per share.
Tangible Book value fell to $ -28.73 per share from $ -25.31.

Company repurchased 35.70 million shares or 4.65 % in II. Quarter.
Interest Coverage Ratio was 6.2. Debt Coverage Ratio was 0.3.

More on CELG's Dividends
 Market Capitalization (Millions) 64,264
 Shares Outstanding (Millions) 733
 Total Debt (Millions $) 21,251
 Revenue (TTM) (Millions $) 14,122
 Net Income (TTM) (Millions $) -111
 Cash Flow (TTM) (Millions $) -5,157
 Capital Exp. (TTM) (Millions $) -315
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012





Celgene Corp does not pay out common stock dividend.

In trailing twelve-month period Celgene Corp earned $ 5.02 cash per share, on a free-cash flow basis 138.04 % of net earning per share.

Book value fell by -30.45 % sequentially to $4.68 per share.
Tangible Book value fell to $ -28.73 per share from $ -25.31.

Company repurchased 35.70 million shares or 4.65 % in II. Quarter.
Interest Coverage Ratio was 6.2. Debt Coverage Ratio was 0.3.

More on CELG's Dividends
 Market Capitalization (Millions) 64,264
 Shares Outstanding (Millions) 733
 Total Debt (Millions $) 21,251
 Revenue (TTM) (Millions $) 14,122
 Net Income (TTM) (Millions $) -111
 Cash Flow (TTM) (Millions $) -5,157
 Capital Exp. (TTM) (Millions $) -315
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 6,012


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PPIH's Profile

Stock Price

PPIH's Financials

Business Description

Fundamentals

Charts & Quotes

PPIH's News

Suppliers

PPIH's Competitors

Customers & Markets

Economic Indicators

PPIH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071